High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac) (2010)
- Authors:
- USP affiliated authors: FANELLI, CAMILLA - FM ; FERNANDES, BIANCA HELENA VENTURA - FM ; FUJIHARA, CLARICE KAZUE - FM ; ZATZ, ROBERTO - FM
- Unidade: FM
- Subjects: INSUFICIÊNCIA RENAL CRÔNICA (INDUZIDO QUIMICAMENTE); NEFROPATIAS (INDUZIDO QUIMICAMENTE); MODELOS ANIMAIS; RATOS; RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP"
-
ABNT
CASTRO, M S de et al. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 12 fev. 2026. , 2010 -
APA
Castro, M. S. de, Fanelli, C., Poppi, E. P. B., Fernandes, B. H. V., Machado, F. G., Malheiros, D. M. A. C., et al. (2010). High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Castro MS de, Fanelli C, Poppi EPB, Fernandes BHV, Machado FG, Malheiros DMAC, Fujihara CK, Zatz R. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. 2010 ; 65 S40.[citado 2026 fev. 12 ] -
Vancouver
Castro MS de, Fanelli C, Poppi EPB, Fernandes BHV, Machado FG, Malheiros DMAC, Fujihara CK, Zatz R. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. 2010 ; 65 S40.[citado 2026 fev. 12 ] - Regression of diabetic nephropathy: no dose-response effect of an angiotensin II antagonist
- Combined Losartan (L) and Hydrocholorothyazide (H) treatment (LH) prevents progression of chronic kidney disease (CKD) resulting from L treatment during lactation (LLac)
- Regressão da nefropatia diabética experimental: Ausência de efeito dose resposta de um antagonista da angiotensina II
- Combined losartan and hydrochlorothiazide prevents progression of renal injury in chronic nephropathy resulting from losartan treatment
- Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model
- Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation
- Associação terapêutica de losartan (L) e hidroclorotiazida (H) previne progressão da lesão renal em modelo de nefropatia crônica resultante da administração de (L) durante a lactação
- Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX)
- Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD)
- Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
